AI review of test results for pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial uses an artificial intelligence tool to look at results from tests used to evaluate pulmonary hypertension. It may help doctors make sense of your past test results, especially heart and lung evaluation results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You have had a right heart catheterization (RHC)
- You had routine heart/lung tests like chest X-ray, ECG, and echocardiogram (ultrasound of the heart)
- Your test results from those visits must be complete enough for the study to analyze
- Your test results must be of good enough quality (not too blurred, missing, or corrupted)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI tool to help doctors decide if you should be tested for pulmonary hypertension (high blood pressure in the lungs), which can be a complication of interstitial lung disease. If the tool suggests you might have it, you may get an echocardiogram (an ultrasound of the heart) and a right heart catheterization (a test to measure pressure in the heart) to find out for sure.
This study uses artificial intelligence to look for signs of pulmonary arterial hypertension (high blood pressure in the lungs) and related heart problems using heart ultrasound images and stethoscope recordings. Participating could help improve detection of this condition.
This study looks at whether a special CT scan of the lungs (CT pulmonary angiography) can give results similar to a more invasive heart catheterization test for measuring blood pressure in the lungs. It may help doctors diagnose and monitor pulmonary hypertension more easily in the future.
This study uses artificial intelligence to find better ways to screen for pulmonary arterial hypertension (a type of high blood pressure in the lungs) in people with systemic sclerosis (scleroderma). The goal is to catch the condition earlier so treatment can start sooner.
This trial uses artificial intelligence to analyze heart ultrasound images and detect blocked arteries in people with suspected coronary artery disease. It aims to see if AI can accurately find problems without needing more invasive tests.
This study uses artificial intelligence to look at imaging scans from people who might have a pulmonary embolism (a blood clot in the lungs). It aims to help doctors better diagnose and treat this condition.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.